Central retinal vein occlusion with therapeutic level of anticoagulation.
Purpose. To describe a patient with two episodes of deep venous thrombosis and factor V Leiden mutation who presented with central retinal vein occlusion (CRVO) despite prophylactic use of warfarin sodium (Coumadin). Methods. A case report of a 44-year-old woman with a history of recurrent deep venous thrombosis and Factor V Leiden mutation was placed on lifelong prophylactic therapy with warfarin. The patient presented with CRVO in the left eye despite therapeutic levels of warfarin. Results. Extensive systemic evaluation disclosed high titers for antinuclear antibody (ANA). Conclusion. Systemic anticoagulation with warfarin may not preclude further thrombotic episodes. In younger patients presenting with retinal vein occlusion and pre-existing multiple thrombophilic risk factors, a multidisciplinary approach is recommended to explore other therapeutic options to avoid further thromboembolic complications.
Salim
Sarwat
S
Hamilton Eye Institute, University of Tennessee Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA.
Lam
Wai-Ching
WC
Hanna
Wahid
W
Thromb Haemost. 1996 Oct;76(4):514-7
8902988
Ophthalmology. 2004 Jun;111(6):1196-200
15177971
Surv Ophthalmol. 2002 May-Jun;47(3):215-38
12052409
Retina. 2006 Mar;26(3):285-91
16508428
Br J Ophthalmol. 1996 Mar;80(3):200-2
8703855